SGLT2 inhibitor treatment may now be considered in broader T2DM population
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Sotirios Tsimikas, MD
Dorairaj Prabhakaran, MD
Deepak Bhatt, MD